Parsonage-Turner Syndrome: An update
1 Institute of Teaching, Research, and Innovation, Liga Contra o Câncer – Natal – Brazil.
2 Postgraduate Program in Biotechnology at Potiguar University, Potiguar University (UnP) – Natal/RN - Brazil.
Review Article
World Journal of Advanced Research and Reviews, 2024, 23(01), 2882–2889
Publication history:
Received on 17 June 2024; revised on 28 July 2024; accepted on 30 July 2024
Abstract:
Parsonage-Turner Syndrome (PTS), known as Neuralgic Amyotrophy or Brachial Plexus Neuritis, is a rare neurological disorder characterized by sudden onset shoulder pain followed by muscle weakness and atrophy. Despite advancements in medical research, the absence of standardized diagnostic and treatment protocols poses significant challenges. This review explores the multifaceted aspects of PTS, including its genetic predispositions, diagnostic advancements, treatment efficacy, and the long-term impacts on patients' quality of life. The heterogeneity of PTS presentations, the lack of specific biomarkers, and the unclear etiology contribute to the complexities in managing this condition. While current treatments vary from conservative to aggressive interventions, their efficacy remains inconsistent due to the syndrome's unpredictable prognosis. The disease's social and psychological impacts necessitate a comprehensive, multidisciplinary approach to patient care. This review underscores the need for further research to elucidate PTS's genetic and immunological underpinnings, develop more accurate diagnostic tools, and establish evidence-based treatment guidelines.
Keywords:
Brachial Plexus Neuritis; Parsonage-Turner Syndrome; Neuralgic Amyotrophy; Physiopathology; Diagnosis; Therapy.
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0